IPLATO LIMITED

Active London

Business and domestic software development

2 employees website.com
Healthcare and wellbeing Business and domestic software development
I

IPLATO LIMITED

Business and domestic software development

Founded 21 Feb 2000 Active London, England 2 employees website.com
Healthcare and wellbeing Business and domestic software development

Previous Company Names

IPLATO LTD 21 Feb 2000 — 11 Oct 2023
Accounts Submitted 28 Nov 2025 Next due 28 Sept 2026 5 months remaining
Confirmation Submitted 23 Feb 2026 Next due 7 Mar 2027 10 months remaining
Net assets £1M £3K 2024 year on year
Total assets £1M £387 2024 year on year
Total Liabilities £9K £4K 2024 year on year
Charges 3
3 satisfied

Contact & Details

Contact

Registered Address

Millbank Tower 21-24 Millbank London SW1P 4QP England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for IPLATO LIMITED (03930219), an active healthcare and wellbeing company based in London, England. Incorporated 21 Feb 2000. Business and domestic software development. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2013–2024)

Cash in Bank

£3.64k

Increased by £1.32k (+57%)

Net Assets

£1.30M

Decreased by £3.46k (-0%)

Total Liabilities

£9.49k

Increased by £3.85k (+68%)

Turnover

N/A

Employees

2

Debt Ratio

1%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

13 Allotments 2,175,355 Shares £534.74m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Nov 2021538,000£10.76£0
23 Mar 2020226,000£1.02m£4.52
24 Jul 2019100,000£200k£2
8 Jul 201915,000£4k£0.25
24 Dec 2018100,000£200k£2

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Huma Therapeutics Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased
Active
Notified 22 Dec 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Peter Tobias Alpsten

Ceased 22 Dec 2021

Ceased

Martin Degaris Rowden

Ceased 22 Dec 2021

Ceased

Group Structure

Group Structure

IPLATO LIMITED Current Company

Charges

Charges

3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
26 Feb 2026OfficersTermination of Murray Ellender as director on 2026-02-26
23 Feb 2026Confirmation StatementConfirmation statement made on 2026-02-21 with updates
28 Nov 2025OtherAudit exemption statement of guarantee by parent company for period ending 31/12/24
28 Nov 2025OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/24
28 Nov 2025AccountsAnnual accounts filed
26 Feb 2026 Officers

Termination of Murray Ellender as director on 2026-02-26

23 Feb 2026 Confirmation Statement

Confirmation statement made on 2026-02-21 with updates

28 Nov 2025 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/24

28 Nov 2025 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

28 Nov 2025 Accounts

Annual accounts filed

Recent Activity

Latest Activity

Termination of Murray Ellender as director on 2026-02-26

1 months ago on 26 Feb 2026

Confirmation statement made on 2026-02-21 with updates

1 months ago on 23 Feb 2026

Audit exemption statement of guarantee by parent company for period ending 31/12/24

4 months ago on 28 Nov 2025

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

4 months ago on 28 Nov 2025

Annual accounts filed

4 months ago on 28 Nov 2025